510(k) K181663

ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel by Genmark Diagnostics, Incorporated — Product Code PAM

K181663 is an FDA 510(k) premarket notification submitted by Genmark Diagnostics, Incorporated for the device "ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel". The FDA issued a decision of Substantially Equivalent on Dec 20, 2018. The device falls under product code PAM (Gram-Positive Bacteria And Their Resistance Markers), a Class II device regulated under 21 CFR 866.3365. Genmark Diagnostics, Incorporated has 6 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 20, 2018
Date Received
Jun 25, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Gram-Positive Bacteria And Their Resistance Markers
Device Class
Class II
Regulation Number
866.3365
Review Panel
MI
Submission Type
510(k)

A qualitive multiplexed in vitro diagnostic device to detect and identify Gram positive bacteria and resistant markers in positive blood cultures.

Need the full FDA record for Genmark Diagnostics, Incorporated? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K181663. Report a data issue: hello@regdatalab.com.